Lip GYH - Search Results

1

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry.

Proietti M, Vitolo M, Harrison SL, Lane DA, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Boriani G, Lip GYH; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Proietti M, et al. Among authors: lip gyh. BMC Med. 2021 Oct 20;19(1):256. doi: 10.1186/s12916-021-02120-3. BMC Med. 2021. PMID: 34666757 Free PMC article.

2

A comparison of cardiovascular risk factors among Indo-Asian and caucasian patients admitted with acute myocardial infarction in Kuala Lumpur, Malaysia and Birmingham, England.

Dhanjal TS, Lal M, Haynes R, Lip G. Dhanjal TS, et al. Int J Clin Pract. 2001 Dec;55(10):665-8. Int J Clin Pract. 2001. PMID: 11777289

3

Statins and the assessment of endothelial function.

Lee KW, Felmeden DC, Lip GY. Lee KW, et al. J Intern Med. 2002 May;251(5):452-3; author reply 453-4. doi: 10.1046/j.1365-2796.2002.00978.x. J Intern Med. 2002. PMID: 11982746 Free article. No abstract available.

4

Tackling malignant hypertension: not so desperate now.

Felmeden DC, Beevers DG, Lip GY. Felmeden DC, et al. Am Heart J. 2002 Aug;144(2):E4. doi: 10.1067/mhj.2002.111542. Am Heart J. 2002. PMID: 12177662 No abstract available.

5

Do protein Z levels influence the prothrombotic state in atrial fibrillation?

Marco P, Marín F, García A, Roldán V, Lip GY. Marco P, et al. Thromb Res. 2002 May 15;106(4-5):269-70. doi: 10.1016/s0049-3848(02)00142-1. Thromb Res. 2002. PMID: 12297137 No abstract available.

6

Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure.

Chin BS, Chung NA, Gibbs CR, Blann AD, Lip GY. Chin BS, et al. Am J Cardiol. 2002 Dec 1;90(11):1258-60. doi: 10.1016/s0002-9149(02)02848-5. Am J Cardiol. 2002. PMID: 12450612 No abstract available.

7

Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.

Felmeden DC, Spencer CG, Belgore FM, Blann AD, Beevers DG, Lip GY. Felmeden DC, et al. Am J Hypertens. 2003 Jan;16(1):11-20. doi: 10.1016/s0895-7061(02)03149-7. Am J Hypertens. 2003. PMID: 12517677

8

Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

Felmeden DC, Spencer CG, Blann AD, Beevers DG, Lip GY. Felmeden DC, et al. J Intern Med. 2003 Jan;253(1):81-91. doi: 10.1046/j.1365-2796.2003.01087.x. J Intern Med. 2003. PMID: 12588540 Free article.

9

Angiogenesis: basic pathophysiology and implications for disease.

Felmeden DC, Blann AD, Lip GY. Felmeden DC, et al. Eur Heart J. 2003 Apr;24(7):586-603. doi: 10.1016/s0195-668x(02)00635-8. Eur Heart J. 2003. PMID: 12657217 Review. No abstract available.

10

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

Marín F, Roldán V, Climent V, Garcia A, Marco P, Lip GY. Marín F, et al. Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,439 results

Search Page